3rd Annual Oncology Market Access Summit Live Chat Software
World Congress
  

3rd Annual Oncology Market Access Summit

2016 Speaking Faculty

Björn Bolinder
Head Oncology, U.S. HEOR
Bristol-Myers Squibb
Joseph C. Cappelleri, PhD
Senior Director, Statistics
Pfizer Inc.
Matthew Farber
Senior Director, Oncology Disease State
Walgreen Co.
Robert Freeman, PhD
Professor and Vice Chair for Research
University of Maryland Eastern Shore School of Pharmacy
Principal, The Freeman Group LLC
Shelley Fuld Nasso Shelley Fuld Nasso
Chief Executive Officer
National Coalition for Cancer Survivorship
Lindee Goh
Partner
Tapestry Networks
Yanni Hao Yanni Hao, PhD
Director, US Oncology Health Economics & Outcomes Research
Novartis Pharmaceuticals Corporation
Dawn Holcombe
Executive Director
Connecticut Oncology Association
Kathleen Lokay
President and Chief Executive Officer
Via Oncology
Aaron Lyss
Director, Value-Based Care
Tennessee Oncology
Debra Madden
Cancer Research Advocate, FDA Patient Representative;
Member, ECOG/ACRIN Cancer Research Group, NCI Cooperative Group
Barbara McAneny, MD
Chief Executive Officer, New Mexico Cancer Center
Past Chair, AMA Board of Trustees
Chief Executive Officer, Innovative Oncology Business Solutions
Leah Ralph
Director, Health Policy
Association of Community Cancer Centers
Richard L. Schilsky Richard L. Schilsky, MD, FACP, FASCO
Chief Medical Officer
American Society of Clinical Oncology
Jeff Sloan, PhD
Professor, Biostatistics & Oncology
Mayo Clinic
Reg Waldeck Reg Waldeck, PhD
Senior Director, Market Access
Celldex Therapeutics

Home :: Health Care :: Legal & IP :: Pharmaceutical :: Live Stream

Opportunities :: Compendium Products :: News :: Videos :: About :: Site Map :: Privacy

© 2016 World Congress | 500 West Cummings Park, Suite 5400 | Woburn, MA 01801 | 800-767-9499